GlassScriptPhysician profile
Krishna S Kishor
NPI 1316967730
$2,418.42
in general payments reported to CMS, 2019-2025
10 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $230 · 2021: $242 · 2022: $665 · 2023: $479 · 2024: $213 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $573.93 | 2020-2024 | Tecnis Iol, Tecnis Iol |
| Alcon Vision LLC | $530.99 | 2022-2025 | Centurion, Clareon |
| Sight Sciences, INC. | $433.62 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $327.40 | 2022-2023 | |
| Ocular Therapeutix, INC. | $193.74 | 2022-2025 | Dextenza |
| Allergan, INC. | $143.71 | 2020-2022 | |
| New World Medical,INC. | $140.52 | 2025 | Streamline, Via360, Kahook Dual Blade |
| Dompe US, INC. | $29.20 | 2024 | Oxervate |
| Rayner Intraocular Lenses Limited | $27.13 | 2024 | Omidria |
| Halozyme INC | $18.18 | 2025 | Hylenex Recombinant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Kishor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.